IPAD-DB ID | S01267 |
Name | 1-(3-(benzyloxy)-2-methylphenyl)piperazine |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 8 H 2 2 N 2 O |
Molecular Weight | 282.4 g/mol |
IUPAC Name | 1-(2-methyl-3-phenylmethoxyphenyl)piperazine |
InChI | InChI=1S/C18H22N2O/c1-15-17(20-12-10-19-11-13-20)8-5-9-18(15)21-14-16-6-3-2-4-7-16/h2-9, 19H, 10-14H2, 1H3 |
InChIKey | LLKMJMQVKKJDAT-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(C=CC=C1OCC2=CC=CC=C2)N3CCNCC3 |
PubChem CID | 25263303 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 282.38 |
Hac(Computed by SwissADME) | 21 |
Volume(Computed by ADMETlab 2.0) | 309.18 |
Density(Computed by ADMETlab 2.0) | 0.913 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 3 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 18 |
Flexibility(Computed by ADMETlab 2.0) | 0.222 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.876 |
LogD(Computed by ADMETlab 2.0) | 3.478 |
logP(Computed by ADMETlab 2.0) | 3.691 |
TPSA(Computed by SwissADME) | 24.5 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 4 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.74 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |